In the last full year, the Office of Assistant Secretary for Preparedness and Response obligated 1.72 billion across 1,050 award actions, for an average action value of 1.64 million. Spending was concentrated in pharmaceutical preparation manufacturing and biotechnology R&D, with ALVOGEN, Bavarian Nordic A/S, and Chartwell RX LLC among the top vendors.
Federal Agency
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Federal Contract Obligations (Last Year)
FPDS summary for the Office of Assistant Secretary for Preparedness and Response (agency ID 7505) covering obligations, awards, vendors, and NAICS activity in the last full year.
Figures reflect FPDS award action records for the analysis window and may include multiple actions associated with the same award or vendor.
About OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE federal contract activity
In the last full year, the Office of Assistant Secretary for Preparedness and Response obligated $1.72 billion across 1,050 awards, for an average award value of $1.64 million. The portfolio reflects a concentrated but multi-award procurement mix, with spending directed toward preparedness, biomedical, and response-related requirements.
Vendor concentration and leading contractors
Vendor obligations were led by ALVOGEN at $227.68 million across 2 awards, followed by BAVARIAN NORDIC A/S at $143.57 million on a single award. CHARTWELL RX LLC, EMERGENT BIOSOLUTIONS CANADA INC, and START2 GROUP, INC. also ranked among the top recipients, indicating a supplier base concentrated in pharmaceutical and biomedical product support.
Industry profile based on NAICS activity
NAICS 325412, Pharmaceutical Preparation Manufacturing, accounted for $1.15 billion across 64 awards and was the dominant obligation category. NAICS 541714, Research and Development in Biotechnology, was the second-largest category at $694.47 million across 358 awards, while smaller but notable obligations flowed to construction, hazardous waste treatment, and management consulting services.
Annual contract trend over the analysis window
The annual trend for 2025 shows $1.72 billion obligated across 1,050 awards, matching the full-year analysis window. With only one year in the period, the trend supports a single-point summary rather than a multi-year comparison, but it confirms a high-volume award environment.
How to interpret this page
This analysis is based on FPDS-observed obligations for Agency ID 7505 over the last full year. Metrics summarize total obligated dollars, award counts, average award value, top vendors, and top NAICS categories as reported in the underlying dataset; no inflation adjustment or additional normalization was applied.
Top Vendors
SELECT
vendor_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__vendor__vendorHeader__vendorName AS vendor_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__purchaserInformation__contractingOfficeAgencyID = '7505'
AND content__award__vendor__vendorHeader__vendorName IS NOT NULL
AND content__award__vendor__vendorHeader__vendorName != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 1 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY vendor_name
)
ORDER BY total_obligated DESC
LIMIT 10
| Vendor | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| ALVOGEN | 227,679,090.00 | 227.68 million | 2 |
| BAVARIAN NORDIC A/S | 143,565,496.00 | 143.57 million | 1 |
| CHARTWELL RX LLC | 114,762,641.76 | 114.76 million | 6 |
| EMERGENT BIOSOLUTIONS CANADA INC | 114,301,000.00 | 114.30 million | 8 |
| START2 GROUP, INC. | 105,217,532.00 | 105.22 million | 4 |
| EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | 102,674,751.00 | 102.67 million | 6 |
| AMGEN USA INC. | 89,975,028.14 | 89.98 million | 1 |
| FRESENIUS KABI, LLC | 86,258,049.27 | 86.26 million | 2 |
| GENENTECH USA, INC | 82,592,051.00 | 82.59 million | 3 |
| SEQIRUS, INC. | 78,056,107.99 | 78.06 million | 8 |
Insight
Over the last full year, the agency obligated $1.72 billion across 1,050 awards, with an average award value of $1.64 million. Obligations are concentrated among a small set of vendors: the top 10 vendors account for $1.14 billion, or roughly 66% of total obligations. The largest recipient, ALVOGEN, received $227.68 million across 2 awards, while several other vendors received between about $78 million and $144 million, indicating a relatively concentrated vendor base with multiple repeat awards.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__purchaserInformation__contractingOfficeAgencyID = '7505'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 1 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10
| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | 1,148,758,244.33 | 1.15 billion | 64 |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 694,474,651.04 | 694.47 million | 358 |
| 236210 | INDUSTRIAL BUILDING CONSTRUCTION | 76,908,300.00 | 76.91 million | 7 |
| 562211 | HAZARDOUS WASTE TREATMENT AND DISPOSAL | 41,222,750.00 | 41.22 million | 3 |
| 541611 | ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES | 40,856,732.72 | 40.86 million | 48 |
| 561612 | SECURITY GUARDS AND PATROL SERVICES | 33,081,204.60 | 33.08 million | 3 |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | 21,215,392.49 | 21.22 million | 90 |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | 16,827,529.49 | 16.83 million | 88 |
| 541512 | COMPUTER SYSTEMS DESIGN SERVICES | 12,811,245.18 | 12.81 million | 28 |
| 492110 | COURIERS AND EXPRESS DELIVERY SERVICES | 10,600,000.00 | 10.60 million | 4 |
Insight
Over the last full year, obligations for the Office of Assistant Secretary for Preparedness and Response were concentrated in pharmaceutical preparation manufacturing (NAICS 325412), which accounted for $1.15 billion across 64 awards, followed by biotechnology R&D (NAICS 541714) at $694.47 million across 358 awards. These two NAICS codes together represented the vast majority of the agency’s $1.72 billion obligated amount, indicating a strong emphasis on medical countermeasure and life sciences acquisition. Remaining obligations were spread across construction, hazardous waste, consulting, security, and other technical services, each at materially lower dollar levels.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__purchaserInformation__contractingOfficeAgencyID = '7505'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 1 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC
| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 1,720,219,621.95 | 1.72 billion | 1,050 |
Insight
During the last full year, the Office of Assistant Secretary for Preparedness and Response recorded $1.72 billion in obligated spending across 1,050 awards, for an average award value of $1.64 million. With only one annual observation provided for 2025, trend direction and year-over-year change cannot be assessed from this window. The data indicate a relatively broad distribution of obligations across a substantial number of awards rather than reliance on a small number of transactions.
Use FPDS Query for deeper analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper market analysis across agencies, vendors, NAICS, and contract trends.
Continue from this last full year view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.